APA (7th ed.) Citation

C, F., TM, D., M, F., N, R., F, R., AD, H., . . . M, W. (2022). Circulating miR-200 family as predictive markers during systemic therapy of metastatic breast cancer. Archives of gynecology and obstetrics, 306(3), 875. https://doi.org/10.1007/s00404-022-06442-2

Chicago Style (17th ed.) Citation

C, Fischer, et al. "Circulating MiR-200 Family as Predictive Markers During Systemic Therapy of Metastatic Breast Cancer." Archives of Gynecology and Obstetrics 306, no. 3 (2022): 875. https://doi.org/10.1007/s00404-022-06442-2.

MLA (9th ed.) Citation

C, Fischer, et al. "Circulating MiR-200 Family as Predictive Markers During Systemic Therapy of Metastatic Breast Cancer." Archives of Gynecology and Obstetrics, vol. 306, no. 3, 2022, p. 875, https://doi.org/10.1007/s00404-022-06442-2.